Upregulation of PI3K/AKT/PTEN pathway is correlated with glucose and glutamine metabolic dysfunction during tamoxifen resistance development in MCF-7 cells

Abstract Tamoxifen resistance is emerging as a big challenge in endocrine therapy of luminal A breast cancer patients. In this study, we aimed to determine the molecular changes of PI3K/AKT/PTEN signaling pathway during tamoxifen-resistance development using gradually increased doses of tamoxifen in...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lama Hamadneh, Rama Abuarqoub, Ala Alhusban, Mohamad Bahader
Format: article
Langue:EN
Publié: Nature Portfolio 2020
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/67fff4cce9114647897b2e2d4a2af510
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!